UC’s top revenue-generating inventions
The University of California received more than $118 million in royalty and fee payments in 2014. Here are the top revenue-generating inventions:
Royalty and fee income (in thousands)
1. Prostate cancer drug, UCLA: $33,353
2. Hepatitis-B vaccine, UC San Francisco: $8,766
3. EGF receptor antibodies, UC San Diego: $6,754
4. Bovine growth hormone, UC San Francisco: $5,747
5. Chromosome painting, Lawrence Livermore National Laboratory: $3,571
Total royalty and fee income, 2014: $118,243
Source: University of California
Start your day right
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
You may occasionally receive promotional content from the Los Angeles Times.
